Clinical trials
Terminated Phase 1 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| ABM Therapeutics Corporation | 1 |
| ABM Therapeutics Shanghai Company Limited | 1 |
| AbGenomics B.V Taiwan Branch | 1 |
| Academic and Community Cancer Research United | 1 |
| Actym Therapeutics, Inc. | 1 |
| Andrew Lowy | 1 |
| Danielle Kim Turgeon | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 23 |
| Colorectal Neoplasms | 7 |
| Melanoma | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Esophageal Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Pancreatic Neoplasms | 3 |
| Sarcoma | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.